NIH has launched a human trial for LASSARAB, a dual-purpose vaccine targeting Lassa fever and rabies. Early animal studies ...

Lassa fever vaccine is one step closer to approval. Lassa virus infections, primarily spread by rodents, can cause a fatal ...

The NIH announced the beginning of a phase 1 first-in-human trial of a vaccine for Lassa fever, a potentially fatal viral hemorrhagic disease for which there is no approved vaccine or treatment.

The NCDC on Wednesday, confirmed 563 Lassa fever cases out of the 2,960 suspected cases of the disease and 103 deaths as of ...

A renowned virologist and former vice-chancellor of Redeemer’s University, Prof. Oyewale Tomori, has warned that Lassa fever ...

The Nigeria Centre for Disease Control and Prevention (NCDC) has recorded 28 new confirmed cases and three deaths from Lassa ...

The Nigeria Centre for Disease Control and Prevention (NCDC) has recorded 28 new confirmed cases and three deaths from Lassa ...

A new report from UK experts says research should be prioritised, including for four of the pathogen families at high risk of ...

NIH-Sponsored Trial of Lassa Vaccine Opens - Viral Hemorrhagic Disease Can be Fatal & Causes Permanent Hearing Loss ...

The UK Health Security Agency has published a list of the 24 pathogen families that could pose the greatest risk to public ...

NIH-sponsored trial of candidate vaccine to prevent Lassa fever begins enrolling participants: Bethesda, Maryland Thursday, March 20, 2025, 18:00 Hrs [IST] A National Institutes o ...